Our Leadership Team

David Ege, PhD

Chief Technical Officer

David Ege is the Chief Technical Officer of ADCT. He has more than 20 years of experience in the pharmaceutical industry, with a focus in biologics, vaccines and novel modalities.

Prior to joining ADCT Dr. Ege was CTO, head of Process Development, Quality and Supply at Seres Therapeutics since 2020. He began his career at Merck in 2003, serving in a variety of technical and leadership roles in R&D, manufacturing and supply chain, in the U.S. and Switzerland. From 2015-2019, Dr. Ege served as Executive Director of Vaccines & Biologics Manufacturing at Merck’s plant in Elkton, VA where he led bulk manufacturing operations for the Gardasil® and Gardasil9® cervical cancer vaccines, as well as adjuvants and Cancidas® – a broad-based anti-fungal medicine made by fermentation. He has contributed to the successful first-in-class licensure and launch of cervical cancer vaccines, Gardasil® (2006) and Gardasil9® (2014), the breakthrough cancer immunotherapy, Keytruda® (2014), and oral live microbiome therapy Vowst™ (2023).

He graduated summa cum laude from Princeton with a BSE in chemical engineering and earned his PhD in chemical engineering from the University of Pennsylvania.

Back to Our Leadership Team